Raimar Löbenberg

Raimar Löbenberg

Net worth: 1 M $ as of 2026-07-30

60 year
Consumer Services
Health Technology
Commercial Services

Profile

Raimar Löbenberg is the founder of RS Therapeutics, Inc., founded in 2018, serving as Chief Scientific Officer since 2018.
Dr. Löbenberg is the founder of BioNxt Solutions, Inc., founded in 2017, serving as Independent Director since 2018.
Current jobs include Director-Drug Development & Innovation Center at the University of Alberta since 2000 and Co-Managing Director at Vektor Pharma TF GmbH.
Former jobs include Independent Chairman at Defence Therapeutics Inc and President of the Canadian Society for Pharmaceutical Sciences from 2014 to 2015.
Education includes a doctorate from Johann Wolfgang Goethe-Universität Frankfurt am Main and an undergraduate degree from The Johannes Gutenberg University of Mainz.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2025-09-28 5,040,000 ( 3.88% ) 1 M $ 2026-07-30

Raimar Löbenberg active positions

CompaniesPositionStart
BIONXT SOLUTIONS INC. Founder 2017-12-11
Corporate Officer/Principal 1999-12-31
RS Therapeutics, Inc.
Founder 2018-10-31
Chief Executive Officer -

Former positions of Raimar Löbenberg

CompaniesPositionEnd
President 2014-12-31
DEFENCE THERAPEUTICS INC. Chairman -
See the detail of Raimar Löbenberg's experience

Training of Raimar Löbenberg

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

81

1st degree connections

8

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies8

Consumer Services

Consumer Services

Consumer Services

Commercial Services

Health Technology

RS Therapeutics, Inc.

Health Technology

Health Technology

  1. Stock Market
  2. Insiders
  3. Raimar Löbenberg